Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company has demonstrated continuous high growth in performance, with a significant increase in orders driven by favorable conditions in downstream industries such as lithium batteries and electronic semiconductors [2] - The company has successfully developed and mass-produced the first domestic open tube X-ray equipment, which enhances its capabilities in high-end semiconductor testing and reduces reliance on imports [3] - The company is advancing its global M&A strategy, having acquired SSTI, a leader in high-end semiconductor fault analysis equipment, which is expected to enhance its performance and expand its business in high-end semiconductor testing [4] Financial Performance Summary - For the first three quarters of 2025, the company achieved revenue of 737 million yuan, a year-on-year increase of 44.01%, and a net profit attributable to shareholders of 125 million yuan, up 18.83% [2] - The company forecasts net profits of 178 million, 317 million, and 462 million yuan for 2025, 2026, and 2027 respectively, with corresponding EPS of 1.08, 1.91, and 2.79 yuan [2] - The projected revenue for 2025 is 1.178 billion yuan, reflecting a year-on-year growth of 59.3% [6] Strategic Developments - The company is focusing on enhancing its core components, AI, and testing equipment capabilities, including a strategic partnership with Silan Technology to develop specialized computing chips for industrial testing [3] - The acquisition of SSTI is expected to contribute an average after-tax profit of no less than 62.7 million yuan from 2026 to 2028, further solidifying the company's position in the high-end semiconductor testing market [4]